Navigation Links
Positive Results Prompt US National Cancer Institute to Make,Gleevec Available To Patients in Post-Surgical Gist Study

strating a clinical benefit, such as improvement in disease-related symptoms or increased survival

Important Safety Information(1)

Severe (NCI Grades 3/4) lab abnormalities (400 mg/day; 600 mg/day)- including neutropenia (10%; 11%), anemia (3%; 9%), thrombocytopenia (0%; 1%), and hepatotoxicity (6%; 8%)-and severe adverse experiences (NCI Grades 3/4), including severe fluid retention (eg, pleural effusion or ascites; 3%; 8%) and superficial edema (6%; 5%), hemorrhage (6%; 11%), abdominal pain (11%; 4%), nausea (6%; 4%), diarrhea (3%; 7%), and musculoskeletal pain (6%; 1%) were reported among patients receiving Gleevec

Some patients (5%) were reported to have severe GI bleeds and/or intratumoral bleeds. GI tumor sites may have been the source of GI bleeds

Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and gastrointestinal (GI) perforation

Severe congestive heart failure and left ventricular dysfunction have occasionally been reported. Most of the patients with reported cardiac events have had other comorbidities and risk factors, including advanced age and previous medical history of cardiac disease. Patients with cardiac disease or risk factors for cardiac failure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction

Dose adjustments ma
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
2. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Protox Announces Positive Clinical Data from Prostate Cancer Study
5. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. Positive ZIO-201 Interim Phase II Sarcoma Data Presented at European Society for Medical Oncology
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
Post Your Comments:
(Date:3/2/2015)... SANTA ANA, Calif. , March 2, 2015 ... premier supplier of child-resistant packaging solutions for ... Co-Founder, Nicholas Kovacevich , has been nominated ... The Excellence in Entrepreneurship Award is ... entrepreneurial spirit – individuals who, by their creativity ...
(Date:3/2/2015)... NEW YORK , March 2, 2015 /PRNewswire/ ... LLC is investigating potential claims on behalf of ... ("Vitae Pharmaceuticals" or the "Company") (NasdaqGM: VTAE -News).  ... Bronstein or his investor relations coordinator ... 212-697-6484. The investigation concerns whether Vitae ...
(Date:3/2/2015)... March 2, 2015  CANTEL MEDICAL CORP. (NYSE: ... Krakauer , CEO, will be presenting at the Sidoti ... The formal presentation is scheduled for 2:00 PM ET ... Hotel, New York . In addition, ... Development, will be available for separate one-on-one meetings during ...
Breaking Medicine Technology:Kush Bottles CEO, Nicholas Kovacevich, Nominated for 2015 "Excellence in Entrepreneurship Award" 2SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Vitae Pharmaceuticals, Inc. 2
... Pharmaceuticals, Inc. (Nasdaq: AUXL ) today announced ... 2011 Healthcare Conference during September 7-9, 2011 at the ... Financial Officer, is scheduled to present an overview of ... ET on Wednesday, September 7, 2011.   ...
... 2011 Wendy R. Fleishman ... Bernstein, LLP announced that Tiffany Littles, 33, of Jacksonville, Florida, ... for severe and lasting injuries caused by Bayer,s birth control ... prescription drug sold without adequate warnings about the risk of ...
Cached Medicine Technology:Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 2Auxilium Pharmaceuticals to Present at the Stifel Nicolaus 2011 Healthcare Conference 3Florida Woman Charges Life-Threatening Blood Clot Caused by Yaz Birth Control Drug According to Lieff Cabraser Heimann & Bernstein, LLP 2
(Date:3/2/2015)... March 02, 2015 Cutler Integrative Medicine ... to the root, gives cutting-edge tips to bring about ... to renew the body by first cleaning house. ... medicine, “We are all Toxic.” Between environmental toxins like ... potential greatness, and our high stress levels, we all ...
(Date:3/2/2015)... 02, 2015 Surgeons at the ... Allegheny Health Network, are exploring an innovative use ... Visual Info Zonal Reminder (VIZR), to assist in the ... Google Glass is a wearable technology with an optical ... format. Wearers communicate with the Internet via natural language ...
(Date:3/2/2015)... GBCHealth, a prominent business coalition ... activities and investments in global health issues, today ... members to serve on the organization’s Board of ... Strategist and Co-founder of Partners In Health, and ... Abbasi, General Manager of Global Health and Medical ...
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to offer ... Analysts Inc and recently added to its catalogue. , ... 2018, the global radiation therapy equipment market is poised ... suggests a holistic analysis of the situation in the ... covers the top market trends. The publication uncovers data ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Just ... (FDA) warned against the use of power morcellators ... fibroid removal surgeries, insurer UnitedHealthCare is poised to ... of those devices. In a notification sent to ... in April, it would require pre-authorization for laparoscopic ...
Breaking Medicine News(10 mins):Health News:Skin and Wellness Power Couple give Quick Tips to Self-Renewal for Spring 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 2Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 3Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 4Health News:Dr. Paul Farmer and Leaders from Chevron, Johnson & Johnson and Merck Join GBCHealth’s Board of Directors 5Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurers’ Decision to Restrict Most Common Form of Hysterectomies 4
... to fortify the cassava plant, a staple root crop ... protein to provide the poor and malnourished with a ... The researchers have further engineered the cassava plant so ... and are refining methods to reduce cyanogens, substances that ...
... likely no one key reason for a particular ... -- Genetics and random environmental factors each play a ... say British and Swedish researchers. , "This study ... looking for a single ,gay gene, or a single ...
... Outstanding Quality and Compliance -, LEXINGTON, Mass., ... it has received the prestigious Supplier,Performance Award from ... recognizes outstanding performance in quality and compliance by,Premier ... award winners. IL,was presented with the honor at ...
... Circadiance launched the,revolutionary SleepWeaver(TM) Nasal CPAP Mask ... the Associated Professional Sleep Societies, SLEEP 2008,which was ... Many sleep apnea patients discontinue their CPAP therapy ... interruption. The,innovative SleepWeaver is the only 100 percent ...
... /PRNewswire-FirstCall/ - SXC Health Solutions Corp.,("SXC" or the ... leading provider of,technology and pharmacy benefits management services, ... its informedRx(R) pharmacy benefit management,("PBM") services with The ... providing its services for more than 6,000 members ...
... MDS Inc. (TSX: MDS, NYSE:,MDZ), a leading provider of ... announced today that the Toronto Stock Exchange,(TSX) accepted the ... bid for a one-year period., The Notice provides ... ending July 2, 2009, if deemed appropriate by the ...
Cached Medicine News:Health News:Fortified cassava could provide a day's nutrition in a single meal 2Health News:Fortified cassava could provide a day's nutrition in a single meal 3Health News:Fortified cassava could provide a day's nutrition in a single meal 4Health News:Genetics, Environment Shape Sexual Behavior 2Health News:Instrumentation Laboratory Receives Performance Award from Premier for Second Consecutive Year 2Health News:Clinical Launch of Innovative Cloth Sleep Apnea Mask Creates Buzz at Sleep Conference 2Health News:The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services 2Health News:The University of Toledo selects SXC Health Solutions (informedRx) to provide pharmacy benefit management services 3Health News:MDS Inc. Announces Normal Course Issuer Bid 2